Article

Arkansas OnlineArkansas Online on 2022-12-13 10:02

Biotech company Amgen to buy drug firm Horizon

Biotechnology giant Amgen is spending more than $26 billion to dive deeper into rare-disease treatments with a deal for drugmaker Horizon Therapeutics.

Related news